These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12111590)

  • 1. Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat.
    Campbell GA; Bartels KE; Arnold C; Healey T; Cowell RL; Lucroy MD; Ronn AM
    Lasers Med Sci; 2002; 17(2):79-85. PubMed ID: 12111590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
    Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
    Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F
    Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
    Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L
    J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
    Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model.
    Rovers JP; Saarnak AE; de Jode M; Sterenborg HJ; Terpstra OT; Grahn MF
    Photochem Photobiol; 2000 Feb; 71(2):211-7. PubMed ID: 10687396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a sheep animal model to optimise photodynamic therapy in the oesophagus.
    Glanzmann TM; Zellweger MP; Borle F; Conde R; Radu A; Ballini JP; Jaquet Y; Pilloud R; van den Bergh H; Monnier P; Andrejevic-Blant S; Wagnières GA
    Lasers Surg Med; 2009 Nov; 41(9):643-52. PubMed ID: 19790242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
    Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
    J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.
    Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
    Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
    Andrejevic Blant S; Ballini JP; van den Bergh H; Fontolliet C; Wagnières G; Monnier P
    Photochem Photobiol; 2000 Mar; 71(3):333-40. PubMed ID: 10732452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
    Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
    J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin.
    Yankovsky I; Bastien E; Yakavets I; Khludeyev I; Lassalle HP; Gräfe S; Bezdetnaya L; Zorin V
    Eur J Pharm Sci; 2016 Aug; 91():172-82. PubMed ID: 27320407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin.
    Wagnieres G; Hadjur C; Grosjean P; Braichotte D; Savary JF; Monnier P; van den Bergh H
    Photochem Photobiol; 1998 Sep; 68(3):382-7. PubMed ID: 9747593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.
    Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P
    Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy.
    Ronn AM; Batti J; Lee CJ; Yoo D; Siegel ME; Nouri M; Lofgren LA; Steinberg BM
    Lasers Surg Med; 1997; 20(4):437-42. PubMed ID: 9142684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
    Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
    Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.